Homepage > Company > Media > Pharma News > 2021 > EU paves way for more Pfizer vaccine shots after extra dose allowed

EU paves way for more Pfizer vaccine shots after extra dose allowed

Europe’s medicines regulator gave the go ahead on Friday for an extra sixth dose to be extracted from the Pfizer-BioNTech COVID-19 vaccine vials, lifting the number of available shots at a time when supplies are short.

EU countries started inoculating people with the Pfizer-BioNTech vaccine two weeks ago, after the European Medicines Agency (EMA) recommended the shot’s conditional approval under an authorisation which allows five doses to be extracted from each vial.

JANUARY 8, 2021

https://www.reuters.com/

Read also

Spinogenix’s ALS hopeful to advance to registrational trial

Spinogenix’s first-in-class ALS treatment, SPG302 has been shown to slow disease progression in 82% of patients during a Phase IIa study.

FDA Approves First Treatment for Rare Thymidine Kinase 2 Deficiency

Thymidine kinase 2 deficiency (TK2d) is an ultra-rare (1.64 cases per 1,000,000 people) often fatal, genetic mitochondrial disease characterized by progressive and severe muscle weakne...

Cencora

Cencora to invest $1bn in US pharma distribution network

Celltrion

Celltrion Signs Licensing Deal with U.S. Kaigene for Two Antibody Drug Candidates